MoneyWorks4Me

Aurobindo Pharma’s unit recalling products in US market over manufacturing issues

27 Aug 2024 Evaluate

Aurobindo Pharma’s unit -- Aurobindo Pharma USA Inc is recalling 240 bottles of pain-relieving medication Healthy Living Acetaminophen, Aspirin (NSAID) and caffeine tablets. As per the latest enforcement report of USFDA, the company is recalling the affected lot due to ‘Missing Label’. Some bottles are missing the manufacturer's label that includes the drug facts information.

The New Jersey-based Aurobindo Pharma USA Inc initiated the Class I recall on July 11. As per the US health regulator, a Class I recall pertains to defective products that can cause serious health problems. 

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..